Stay updated on Daratumumab Combination in Untreated Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combination in Untreated Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combination in Untreated Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and a comprehensive list of locations across various countries, while also removing outdated location details and references to previous studies. Notably, the total number of study locations has been revised from 164 to 160.SummaryDifference10%
- Check24 days agoChange DetectedThe webpage has been updated to reflect new timelines for various clinical measures, including progression-free survival (PFS) and overall survival (OS), extending the duration from randomization to 8.3 years in some cases. Additionally, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) details have been clarified, emphasizing the importance of quality of life assessments in the study.SummaryDifference16%
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
Stay in the know with updates to Daratumumab Combination in Untreated Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combination in Untreated Multiple Myeloma Clinical Trial page.